Stay updated on HERV-W Antagonist GNbAC1 Clinical Trial
Sign up to get notified when there's something new on the HERV-W Antagonist GNbAC1 Clinical Trial page.
Latest updates to the HERV-W Antagonist GNbAC1 Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check19 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference5%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe website has added new features, while several detailed data fields and options for downloading study information in various formats have been removed.SummaryDifference7%
- Check41 days agoChange DetectedSeveral key health-related links have been removed, including those from MedlinePlus and PubMed, which may impact access to important genetic and medical information.SummaryDifference0.7%
- Check48 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new links related to genetics and multiple sclerosis, as well as new data fields for study information, while removing the previous version 2.12.1.SummaryDifference9%
- Check55 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.1%
Stay in the know with updates to HERV-W Antagonist GNbAC1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HERV-W Antagonist GNbAC1 Clinical Trial page.